Toxicity assessment of doxycycline-aided artificial intelligence-assisted drug design targeting candidate 16S rRNA methyltransferase gene
Even though the in silico studies show efficacy and safety, still there is need of in vivo trials to investigate the hidden medical aspects. By addressing existing constraints, presenting a non-invasive approach to infections, and providing viable substitutes for traditional surgical procedures, this work considerably expands the knowledge about newer methods and also helps to understand deep insights of dug design mechanism for treatment.
Authors
- Madiha Khan (ORCID: https://orcid.org/0000-0003-1550-0887)
- Muhammad Shoaib (ORCID: https://orcid.org/0000-0003-1296-5005)
- Hira Mubeen (ORCID: https://orcid.org/0000-0002-4900-4497)
- Saima Jabeen (ORCID: https://orcid.org/0000-0002-6542-9436)
- Nagina Rafiq
Institutions
- University of Central Punjab (PK)
- Allied Hospital (PK)
- University of Faisalabad (PK)
- Hera General Hospital (SA)
Publication Details
- Journal
- BMC Pharmacology and Toxicology
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1186/s40360-025-00875-6
- Primary Topic
- Pharmacogenetics and Drug Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00